Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance

Qun Wang1, Zhaojing Dong, Xianglan Liu

  • 1Department of Immunology, Shandong University School of Medicine, Jinan, Shangdong, China.

Diabetes
|August 31, 2013
PubMed

Insights

Programmed cell death-4 (PDCD4) deficiency surprisingly protected mice from obesity and insulin resistance. PDCD4 inhibition improved energy expenditure and reduced inflammation, suggesting PDCD4 as a potential therapeutic target for metabolic diseases.

Area of Science:

  • Metabolic disease research
  • Cellular and molecular biology
  • Inflammation and immunology

Background:

  • Programmed cell death-4 (PDCD4) is a protein translation inhibitor with known proinflammatory effects.
  • The specific role of PDCD4 in the development of obesity and associated metabolic dysfunction remains largely uncharacterized.

Purpose of the Study:

  • To investigate the impact of PDCD4 on diet-induced obesity, inflammation, and insulin resistance.
  • To elucidate the molecular mechanisms underlying PDCD4's influence on metabolic homeostasis.

Main Methods:

  • Utilized high-fat diet (HFD)-fed wild-type and PDCD4-deficient (PDCD4(-/-)) mice.
  • Assessed phenotypic changes including body weight, fat mass, energy expenditure, and insulin sensitivity.
  • Analyzed white adipose tissue (WAT) for macrophage infiltration, inflammatory cytokine levels, and endoplasmic reticulum stress.
  • Investigated the expression of liver X receptor-alpha (LXR-α) and its downstream targets.

Main Results:

  • PDCD4(-/-) mice exhibited a lean phenotype and improved insulin sensitivity on an HFD.
  • These mice displayed increased energy expenditure, reduced WAT inflammation, and alleviated hepatic steatosis.
  • PDCD4 deficiency led to elevated LXR-α expression and its target genes, improving lipid metabolism and reducing ER stress in WAT.

Conclusions:

  • PDCD4 deficiency confers protection against diet-induced obesity, adipose tissue inflammation, and insulin resistance.
  • This protective effect is mediated by the restoration of LXR-α expression and improved lipid homeostasis.
  • PDCD4 emerges as a promising therapeutic target for managing obesity and related metabolic disorders.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...